Yoon Hai Jeon, Lee Jong Jin, Kim Yu Kyeong, Kim Sang Eun
Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul, Korea.
Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyungwon-gil, Songpa-gu, Seoul, 138-736 Korea.
Nucl Med Mol Imaging. 2011 Jun;45(2):132-8. doi: 10.1007/s13139-011-0082-z. Epub 2011 Apr 20.
This study aims to compare the performance of contrast-enhanced computed tomography (CeCT) and 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in detecting small tumor implants and metastatic lymph nodes (LNs) in the abdominopelvic cavity in patients with colorectal cancer.
We enrolled 16 patients who were clinically suspected of experiencing a recurrence (6 male, 10 female; mean age 61 ± 14 years). All subjects underwent CeCT and PET/CT, and the performance of these methods was compared with regard to detecting recurrences. The final diagnosis of a recurrence was made clinically.
CeCT identified 38 lesions in 12 patients, all of which were detected by PET/CT. PET/CT found 27 additional lesions in 8 patients, comprising 9 seeding nodules (2 in the right upper quadrant of the abdomen and 7 in the pelvic cavity) and 18 LNs (2 celiac, 2 paraaortic, 2 hepatic hilar, 11 common iliac, 1 external iliac). Most additional lesions were located in the pelvic cavity (approximately 78% of seeding nodules and 67% of lymph nodes). The maximum standardized uptake value (SUVmax) of the additional seeding nodules that were detected solely by PET/CT was significantly higher compared with the CeCT- and PET/CT-confirmed nodules (5.5 ± 4.2 vs. 2.9 ± 2.5, p = 0.03). The seeding nodules that were detected only by PET/CT were significantly smaller than the CeCT- and PET/CT-confirmed nodules (long axis: 1.0 ± 0.3 cm vs. 2.0 ± 1.1 cm, p = 0.001; short axis: 0.8 ± 0.3 cm vs. 1.4 ± 0.8 cm, p = 0.004; mean of both axes: 0.9 ± 0.3 cm vs. 1.7 ± 0.9 cm, p = 0.001). Similarly, PET/CT-only-detected LNs were significantly smaller than CeCT- and PET/CT-identified LNs (0.7 ± 0.1 cm vs. 2.3 ± 1.2 cm, p < 0.0001).
PET/CT is superior to CeCT in detecting seeding nodules and metastatic LNs in patients with recurrent colorectal cancer. Specifically, PET/CT detects subcentimeter lesions in anatomically deformed pelvic cavities.
本研究旨在比较对比增强计算机断层扫描(CeCT)和18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)在检测结直肠癌患者腹腔和盆腔内小肿瘤种植灶及转移性淋巴结(LNs)方面的性能。
我们纳入了16例临床怀疑复发的患者(6例男性,10例女性;平均年龄61±14岁)。所有受试者均接受了CeCT和PET/CT检查,并比较了这些方法在检测复发方面的性能。复发的最终诊断由临床做出。
CeCT在12例患者中发现了38个病灶,所有这些病灶均被PET/CT检测到。PET/CT在8例患者中又发现了27个病灶,包括9个种植结节(2个位于右上腹,7个位于盆腔)和18个淋巴结(2个腹腔干旁、2个腹主动脉旁、2个肝门、11个髂总、1个髂外)。大多数额外病灶位于盆腔(约78%的种植结节和67%的淋巴结)。仅由PET/CT检测到的额外种植结节的最大标准化摄取值(SUVmax)显著高于CeCT和PET/CT均确认的结节(5.5±4.2 vs. 2.9±2.5,p = 0.03)。仅由PET/CT检测到的种植结节明显小于CeCT和PET/CT均确认的结节(长轴:1.0±0.3 cm vs. 2.0±1.1 cm,p = 0.